Phibro Animal Health Corporation (NASDAQ:PAHC) COO Larry Lee Miller sold 32,459 shares of the stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $35.59, for a total transaction of $1,155,215.81. Following the completion of the sale, the chief operating officer now owns 4,237 shares of the company’s stock, valued at approximately $150,794.83. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Phibro Animal Health Corporation (NASDAQ PAHC) traded up 2.57% on Thursday, hitting $35.95. 185,283 shares of the stock were exchanged. The company has a 50 day moving average of $38.35 and a 200 day moving average of $33.49. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25. The stock has a market capitalization of $1.43 billion, a P/E ratio of 22.33 and a beta of 1.36.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.04. The business had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 earnings per share. On average, equities research analysts forecast that Phibro Animal Health Corporation will post $1.57 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is presently 24.69%.

TRADEMARK VIOLATION WARNING: “Insider Selling: Phibro Animal Health Corporation (PAHC) COO Sells 32,459 Shares of Stock” was originally reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/07/insider-selling-phibro-animal-health-corporation-pahc-coo-sells-32459-shares-of-stock.html.

A number of equities research analysts have issued reports on PAHC shares. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Thursday, May 11th. BidaskClub upgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Credit Suisse Group increased their target price on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research report on Thursday, August 31st. Finally, Bank of America Corporation reiterated an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $33.33.

Several hedge funds have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd bought a new stake in shares of Phibro Animal Health Corporation in the second quarter worth $386,000. Susquehanna International Group LLP bought a new stake in shares of Phibro Animal Health Corporation in the second quarter worth $219,000. Gotham Asset Management LLC lifted its position in shares of Phibro Animal Health Corporation by 63.6% in the second quarter. Gotham Asset Management LLC now owns 38,135 shares of the company’s stock worth $1,413,000 after purchasing an additional 14,822 shares in the last quarter. Janus Henderson Group PLC bought a new stake in shares of Phibro Animal Health Corporation in the second quarter worth $6,353,000. Finally, Goldman Sachs Group Inc. lifted its position in shares of Phibro Animal Health Corporation by 161.5% in the second quarter. Goldman Sachs Group Inc. now owns 167,593 shares of the company’s stock worth $6,209,000 after purchasing an additional 103,497 shares in the last quarter. 48.35% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.